{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-025989","form_type":"8-K","ticker":"PMHS","cik":"0001265521","company_name":"Polomar Health Services, Inc.","filed_at":"2025-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.549102+00:00","generated_at":"2026-05-17T09:09:40.387277+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Polomar Health partners with ForHumanity; $750K guaranteed for exclusive marketing of inhalable drugs","bullets":["Guaranteed payments of $750K; $200K already received, with remaining $500K due by Oct 31, 2025.","Exclusivity for inhalable sildenafil and eletriptan through March 31, 2026, extendable via revenue milestones (e.g., $1.5M by Mar 31, 2026; $3M by Jun 30, 2026; $8M for FY 2026).","Initial term 42 months (Mar 17, 2025 – Sep 16, 2028) with automatic renewals if average annual revenues meet $3M (first renewal) and $6M (second renewal).","Fulfillment by Polomar Specialty Pharmacy; IG4 handles account management; additional $50K advance due by Sep 15, 2025.","Product pricing capped at 3% annual increase during initial term; Polomar must reserve 8,000 kits of each product for ForHumanity."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-025989","json":"https://secwatch.observer/filing/0001641172-25-025989.json","markdown":"https://secwatch.observer/filing/0001641172-25-025989.md","text":"https://secwatch.observer/filing/0001641172-25-025989.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1265521/000164117225025989/0001641172-25-025989-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1265521/000164117225025989/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:09:40.387277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}